Lab
Laboratorio Clinico Y Bacteriologico Rodriguez INC
Laboratorio Clinico Y Bacteriologico Rodriguez INC was paid $2.33M by Medicaid between Jan 2018 and Nov 2024, across 75 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 13% of everything it billed.
33Billing provider infoLABORATORIO CLINICO Y BACTERIOLOGICO RODRIGUEZ INC
LAS PIEDRAS, PR 00771
LAS PIEDRAS, PR 00771
33aNPI1568448355assigned 12/22/2005
33bProvider typeClinical Medical Laboratory
28Total paid$2.33M
24GClaims197,691
24DCodes billed75
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#37 of 777
Median peer was paid$278K
This provider vs. median8.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 37,826 | $295K | |
| 2019 | 32,837 | $294K | |
| 2020 | 23,364 | $299K | |
| 2021 | 31,177 | $464K | |
| 2022 | 22,977 | $333K | |
| 2023 | 25,364 | $328K | |
| 2024incomplete | 24,146 | $312K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 13% | 17,005 | 16,291 | $300K |
| 80061 | Lipid panel | 11% | 18,739 | 17,980 | $255K |
| 80053 | Comprehensive metabolic panel | 9.2% | 19,173 | 18,171 | $213K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.8% | 3,627 | 3,423 | $182K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.1% | 23,470 | 21,937 | $166K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.7% | 4,984 | 4,763 | $133K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.7% | 3,061 | 2,822 | $133K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.1% | 10,159 | 9,764 | $96K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.9% | 3,731 | 3,522 | $91K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.9% | 5,855 | 3,814 | $91K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.3% | 1,623 | 1,497 | $53K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.2% | 1,547 | 1,422 | $51K |
63 more codes
| 84153 | 1.9% | 2,657 | $43K | |
| 86738 | 1.6% | 3,076 | $38K | |
| 82607 | 1.6% | 2,657 | $37K | |
| 84439 | 1.6% | 4,459 | $36K | |
| 82274 | 1.6% | 2,817 | $36K | |
| 82043 | 1.5% | 6,792 | $34K | |
| 81001 | 1.5% | 12,735 | $34K | |
| 86701 | 1.4% | 3,906 | $33K | |
| 81000 | 1.0% | 7,728 | $24K | |
| 87088 | 1.0% | 2,842 | $24K | |
| 86328 | <1% | 1,162 | $22K | |
| 84436 | <1% | 3,414 | $20K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,396 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,525 | $17K |
| 84479 | <1% | 3,061 | $17K | |
| 86592 | <1% | 3,665 | $14K | |
| 80074 | <1% | 277 | $13K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,175 | $13K |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 852 | $12K |
| 86803 | <1% | 536 | $7K | |
| G0433 | Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening | <1% | 636 | $7K |
| 86038 | <1% | 570 | $6K | |
| 82570 | <1% | 1,037 | $5K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 413 | $5K |
| 82951 | <1% | 380 | $5K | |
| 85730 | <1% | 846 | $4K | |
| 85610 | <1% | 1,201 | $4K | |
| 85027 | <1% | 763 | $4K | |
| 85651 | <1% | 975 | $3K | |
| 86140 | <1% | 603 | $3K | |
| 84550 | <1% | 529 | $2K | |
| 82952 | <1% | 392 | $2K | |
| 82947 | <1% | 503 | $2K | |
| 87186 | <1% | 264 | $1K | |
| 87177 | <1% | 343 | $1K | |
| 82950 | <1% | 283 | $1K | |
| 85652 | <1% | 542 | $1K | |
| 84703 | <1% | 169 | $1K | |
| 84156 | <1% | 328 | $829.96 | |
| 84460 | <1% | 229 | $821.95 | |
| 84450 | <1% | 229 | $802.36 | |
| 86696 | <1% | 45 | $726.94 | |
| 83001 | <1% | 39 | $680.75 | |
| 86431 | <1% | 131 | $625.13 | |
| 82728 | <1% | 49 | $485.70 | |
| 80050 | General health panel | <1% | 647 | $432.25 |
| 83655 | <1% | 36 | $411.85 | |
| 81003 | <1% | 168 | $382.00 | |
| 86695 | <1% | 31 | $364.34 | |
| 82746 | <1% | 25 | $343.85 | |
| 86804 | <1% | 18 | $263.86 | |
| 87899 | <1% | 14 | $247.00 | |
| 86430 | <1% | 48 | $224.20 | |
| 84146 | <1% | 12 | $218.16 | |
| 82785 | <1% | 14 | $205.53 | |
| 84702 | <1% | 13 | $183.63 | |
| 86800 | <1% | 12 | $152.70 | |
| 83550 | <1% | 24 | $149.88 | |
| 83540 | <1% | 27 | $130.44 | |
| 82270 | <1% | 25 | $72.28 | |
| 86901 | <1% | 13 | $36.44 | |
| 86900 | <1% | 13 | $36.44 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 346 | $0.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHERNANDEZ, REINA (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Laboratorio Clnico Y Bacteriologico Rodriguez INC | Humacao, PR | $144K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.